Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zenarestat (CI-1014, FK-366, FR-74366) is an aldose reductase inhibitor being studied as a treatment for diabetic neuropathy and cataracts.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 877.00 | |
50 mg | 6-8 weeks | $ 1,140.00 | |
100 mg | 6-8 weeks | $ 1,820.00 |
Description | Zenarestat (CI-1014, FK-366, FR-74366) is an aldose reductase inhibitor being studied as a treatment for diabetic neuropathy and cataracts. |
Synonyms | CI1014, FR74366, FK-366, CI-1014, FR 74366, FR-74366 |
Molecular Weight | 441.64 |
Formula | C17H11BrClFN2O4 |
CAS No. | 112733-06-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zenarestat 112733-06-9 FK366 CI1014 FR74366 FK-366 CI-1014 CI 1014 FR 74366 FR-74366 FK 366 inhibitor inhibit